A Live Attenuated H7N3 Influenza Virus Vaccine is Well-tolerated and Immunogenic in a Phase I Trial in Healthy Adults

BACKGROUND: Live attenuated influenza vaccines (LAIV) are being developed and tested against a variety of influenza viruses with pandemic potential. We describe the results of an open label Phase I trial of a live attenuated H7N3 virus vaccine. METHODS AND FINDINGS: The H7N3 BC 2004/AA ca virus is a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Talaat, Kawsar R., Karron, Ruth A., Callahan, Karen A., Luke, Catherine J., DiLorenzo, Susan C., Chen, Grace L., Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Murphy, Brian R., Kemble, George, Subbarao, Kanta
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771405/
https://ncbi.nlm.nih.gov/pubmed/19464558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.03.082
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items